
    
      This is a randomized, double blinded , controlled, two-center study assessing the
      feasibility, efficacy and safety of intravitreal ranibizumab injection applied as a
      preoperative adjunct treatment before vitrectomy surgery in severe proliferative diabetic
      retinopathy (PDR). Comparator arm consists of patients receiving standard vitrectomy alone
      with sham intravitreal injection preoperatively.
    
  